Seminar: Claes Gustafsson

The Battle Against SARS-CoV-2: How a biotech company with Umeå roots became a critical link to tame COVID 19

Claes Gustafsson, PhD (Umeå University), co-founder & CCO of ATUM (formerly DNA2.0), Newark, California, USA

Recent publication:
Cameroni, Elisabetta et al. “Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.” Nature vol. 602,7898 (2022): 664-670. doi:10.1038/s41586-021-04386-2 (link)

Map link to seminar room